BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patil M, Singh S, Henderson J, Krishnamurthy P. Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link? J Cell Physiol 2021;236:3366-82. [PMID: 33078408 DOI: 10.1002/jcp.30109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Au TY, Wiśniewski OW, Benjamin S, Kubicki T, Dytfeld D, Gil L. G6PD deficiency-does it alter the course of COVID-19 infections? Ann Hematol 2023;:1-8. [PMID: 36905446 DOI: 10.1007/s00277-023-05164-y] [Reference Citation Analysis]
2 Stincarelli MA, Arvia R, Giannecchini S. Extracellular vesicles engagement during respiratory viruses infection. Aspects of Molecular Medicine 2023. [DOI: 10.1016/j.amolm.2023.100004] [Reference Citation Analysis]
3 Schiavello M, Vizio B, Bosco O, Pivetta E, Mariano F, Montrucchio G, Lupia E. Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation. Int J Mol Sci 2023;24. [PMID: 36768242 DOI: 10.3390/ijms24031920] [Reference Citation Analysis]
4 Guo Z, Yi S. Bone Marrow Mesenchymal Stem Cells (BMSC) from Exosome with High miR-184 Level Ameliorates Sepsis. j biomater tissue eng 2023;13:24-30. [DOI: 10.1166/jbt.2023.3218] [Reference Citation Analysis]
5 Wang F, Suo XG, Wang C, Wang JN, He XY, Wang FC, Jin J, Wen JG, Ni WJ, Shen BX, Meng XM. Highly pathogenic coronaviruses and the kidney. Biomed Pharmacother 2022;156:113807. [PMID: 36242850 DOI: 10.1016/j.biopha.2022.113807] [Reference Citation Analysis]
6 Tian Y, Cheng C, Wei Y, Yang F, Li G. The Role of Exosomes in Inflammatory Diseases and Tumor-Related Inflammation. Cells 2022;11:1005. [DOI: 10.3390/cells11061005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
7 Rajagopalan V, Cao H. Cardiovascular Applications of Artificial Intelligence in Research, Diagnosis, and Disease Management. Biomedical and Business Applications Using Artificial Neural Networks and Machine Learning 2022. [DOI: 10.4018/978-1-7998-8455-2.ch004] [Reference Citation Analysis]
8 李 卓. Research Advance of Exosome in Infectious Diseases. ACM 2022;12:1735-1740. [DOI: 10.12677/acm.2022.123250] [Reference Citation Analysis]
9 Chong PY, Iqbal J, Yeong J, Aw TC, Chan KS, Chui P. Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies. Front Mol Biosci 2021;8:658932. [PMID: 34765640 DOI: 10.3389/fmolb.2021.658932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Harishkumar M, Radha M, Yuichi N, Muthukalianan GK, Kaoru O, Shiomori K, Sakai K, Nozomi W. Designer Exosomes: Smart Nano-Communication Tools for Translational Medicine. Bioengineering (Basel) 2021;8:158. [PMID: 34821724 DOI: 10.3390/bioengineering8110158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Rasmi Y, Babaei G, Nisar MF, Noreen H, Gholizadeh-Ghaleh Aziz S. Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19. Comp Clin Path 2021;:1-17. [PMID: 34539310 DOI: 10.1007/s00580-021-03269-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Mosquera-Heredia MI, Morales LC, Vidal OM, Barceló E, Silvera-Redondo C, Vélez JI, Garavito-Galofre P. Exosomes: Potential Disease Biomarkers and New Therapeutic Targets. Biomedicines 2021;9:1061. [PMID: 34440265 DOI: 10.3390/biomedicines9081061] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
13 Liu Q, Li S, Dupuy A, Mai HL, Sailliet N, Logé C, Robert JH, Brouard S. Exosomes as New Biomarkers and Drug Delivery Tools for the Prevention and Treatment of Various Diseases: Current Perspectives. Int J Mol Sci 2021;22:7763. [PMID: 34360530 DOI: 10.3390/ijms22157763] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Haruta S. Correlation between Coronavirus Disease 2019 and Heart Failure: A Review. J Regen Biol Med 2021. [DOI: 10.37191/mapsci-2582-385x-3(4)-081] [Reference Citation Analysis]
15 Estrada E. Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions. Viruses 2021;13:897. [PMID: 34066091 DOI: 10.3390/v13050897] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Zhao Z, Xiao Y, Xu L, Liu Y, Jiang G, Wang W, Li B, Zhu T, Tan Q, Tang L, Zhou H, Huang X, Shan H. Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment. ACS Appl Mater Interfaces 2021;13:20995-1006. [PMID: 33930273 DOI: 10.1021/acsami.1c02755] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 17.5] [Reference Citation Analysis]
17 Casari I, Manfredi M, Metharom P, Falasca M. Dissecting lipid metabolism alterations in SARS-CoV-2. Prog Lipid Res 2021;82:101092. [PMID: 33571544 DOI: 10.1016/j.plipres.2021.101092] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 20.5] [Reference Citation Analysis]